Insider Transactions in Q3 2024 at 4 D Molecular Therapeutics, Inc. (FDMT)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 16
2024
|
Scott Bizily Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
500
-6.87%
|
$8,000
$16.33 P/Share
|
|
Sep 16
2024
|
Scott Bizily Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+6.43%
|
$3,000
$6.49 P/Share
|
|
Aug 19
2024
|
Scott Bizily Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
500
-6.87%
|
$7,500
$15.0 P/Share
|
|
Aug 19
2024
|
Scott Bizily Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+6.43%
|
$3,000
$6.49 P/Share
|
|
Jul 16
2024
|
Scott Bizily Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,750
-20.51%
|
$47,250
$27.11 P/Share
|
|
Jul 16
2024
|
Scott Bizily Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,750
+9.6%
|
$12,250
$7.27 P/Share
|
|
Jul 11
2024
|
Scott Bizily Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,996
-22.74%
|
$49,900
$25.0 P/Share
|
|
Jul 11
2024
|
Scott Bizily Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,996
+18.53%
|
$29,940
$15.78 P/Share
|
|
Jul 10
2024
|
David Kirn Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
12,923
-1.21%
|
$284,306
$22.49 P/Share
|
|
Jul 10
2024
|
David Kirn Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,923
+0.6%
|
$193,845
$15.1 P/Share
|
|
Jul 01
2024
|
Scott Bizily Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
4,248
-70.98%
|
$89,208
$21.36 P/Share
|
|
Jul 01
2024
|
Scott Bizily Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,248
+31.51%
|
$29,736
$7.27 P/Share
|